[ad_1]
This article is over a month old and may contain outdated advice from authorities regarding coronary heart disease.
Stay up to date on the NRK overview or on the FHI website.
According to the Wall Street Journal, Pfizer can only administer 50 million vaccines before the New Year. Enough for 25 million people.
The plan was to administer twice as much, that is, 100 million doses. However, the company believes that delivery issues will have no consequences for the plan to deliver 1 billion vaccines in 2021.
Biontech, Fosun Pharma and Pfizer
The German pharmaceutical company BioNTech reports that its coronary vaccine has been shown to be 95 percent effective. The UK will start vaccinating in December.
The BNT162b2 vaccine relies on your body’s system for building things. The vaccine is just building instructions for the cells. The instructions are based on the same codes that cells use all the time for this purpose. These are called mRNAs or “messenger ribonucleic acids.”
What happens is the following:
The vaccine is injected into your body. The information from the vaccine reaches the machines in the cells that make proteins. These machines build copies of the so-called “spike protein” of the coronavirus. These proteins are secreted by cells and detected by the immune system. The immune system reacts in the same way as if the real coronavirus had entered the body. Antibodies are produced and the immune system remembers that the coronavirus is something foreign to react to.
You have been vaccinated.
– The expansion of the raw material supply line took longer than expected. It is important to emphasize that the results of the clinical trials lagged slightly behind the initial estimates, a company spokesperson told the newspaper.
At the same time, Pfizer found that some of the raw materials they had access to at an early stage were not of sufficient quality.
“We have fixed it, but we could not do it in time to reach the delivery estimates for this year,” a person who has worked on the development of the vaccine told the Wall Street Journal.
Trouble for the British
The delivery problems could have consequences for the UK, which approved the Pfizer vaccine and ordered 40 million doses.
The news came yesterday that the British are scheduled to start vaccinating from next week.
British authorities are now working to make a list of who should be given priority. Initially, there are 800,000 doses that can vaccinate 400,000 people.
Right now, 50 hospitals are preparing to start vaccinating.
Millions of orders
The vaccine has not yet been approved by the EUS Agency, but the British have used emergency procedures to have limited use.
The Pfizer vaccine is given in two doses three weeks apart.
The world has almost been lining up to place orders after it became clear that the German / American vaccine project will be 95 percent effective.
The US authorities have ordered 100 million doses of this vaccine, with the possibility of requesting another 500 million.
The EU has requested 200 million doses, while Japan has placed an order for 120 million doses.
Norway also hopes to be able to start mass vaccination with the Pfizer vaccine, but depends on the EU approving it first. This is expected to happen at a meeting on December 29.
